A “fit and healthy” woman, Marie Anne August, experienced a “ripping” and bubbling” feeling in her chest. The 45-year-old was ...

A decade after bringing Transcatheter Aortic Valve Replacement (TAVR) to Alaska, doctors at Providence Alaska Medical Center ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

Aortic valve stenosis' is an often-overlooked condition and a growing health concern in ageing societies such as Thailand. With an increasing elderly population and a rise in age-related valve ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial’s ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...

Abstract: For aortic dissection, we aim to synthesize contrast-enhanced computed tomography (CECT) from non-contrast-enhanced CT (NCE-CT), avoiding the possible side effects caused by contrast agents ...

Bob Lowth Ford General Manager Todd Moudry had long been in good health, so when he was diagnosed with an ascending aortic aneurysm in 2018, he could hardly believe it was true. The discovery traces ...

Lp(a) (lipoprotein(a)) is an independent risk factor for calcific aortic valve stenosis (CAVS). Whether patients with CAVS and high Lp(a) levels are at higher risk of valvular or cardiovascular events ...

Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China Background: Calcific aortic valve stenosis (CAVS) is a common cardiovascular ...